Cassava Sciences, Inc.
SAVA
$2.18
$0.041.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -22.74% | 13.76% | 7.39% | 6.38% | 25.69% |
| Gross Profit | 22.74% | -13.76% | -7.39% | -6.38% | -25.69% |
| SG&A Expenses | -55.18% | 289.63% | 336.95% | 386.71% | 367.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.18% | 36.98% | 33.62% | 38.85% | 44.21% |
| Operating Income | 38.18% | -36.98% | -33.62% | -38.85% | -44.21% |
| Income Before Tax | -701.24% | -51.95% | 74.96% | 81.49% | 82.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -701.24% | -51.95% | 74.96% | 81.49% | 82.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -701.24% | -51.95% | 74.96% | 81.49% | 82.93% |
| EBIT | 38.18% | -36.98% | -33.62% | -38.85% | -44.21% |
| EBITDA | 38.26% | -37.91% | -34.49% | -39.77% | -45.00% |
| EPS Basic | -553.86% | -30.52% | 81.00% | 84.18% | 82.13% |
| Normalized Basic EPS | -184.95% | -13.57% | 80.44% | 74.76% | 73.31% |
| EPS Diluted | -82.09% | 30.29% | 37.55% | 39.88% | 35.71% |
| Normalized Diluted EPS | -178.84% | -12.39% | 79.89% | 74.20% | 72.73% |
| Average Basic Shares Outstanding | 11.10% | 12.76% | 10.47% | 7.85% | 5.50% |
| Average Diluted Shares Outstanding | 10.40% | 12.03% | 11.12% | 8.51% | 6.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |